181 related articles for article (PubMed ID: 30877512)
1. Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells.
Diaz-Aragon R; Ramirez-Ricardo J; Cortes-Reynosa P; Simoni-Nieves A; Gomez-Quiroz LE; Perez Salazar E
Mol Cell Biochem; 2019 Jul; 457(1-2):119-132. PubMed ID: 30877512
[TBL] [Abstract][Full Text] [Related]
2. Migration and invasion induced by linoleic acid are mediated through fascin in MDA-MB-231 breast cancer cells.
Gonzalez-Reyes C; Marcial-Medina C; Cervantes-Anaya N; Cortes-Reynosa P; Salazar EP
Mol Cell Biochem; 2018 Jun; 443(1-2):1-10. PubMed ID: 29052029
[TBL] [Abstract][Full Text] [Related]
3. Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
Serna-Marquez N; Diaz-Aragon R; Reyes-Uribe E; Cortes-Reynosa P; Salazar EP
Med Oncol; 2017 Jun; 34(6):111. PubMed ID: 28456993
[TBL] [Abstract][Full Text] [Related]
4. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
5. Linoleic acid induces an increased response to insulin in MDA-MB-231 breast cancer cells.
Rodriguez-Monterrosas C; Diaz-Aragon R; Cortes-Reynosa P; Salazar EP
J Cell Biochem; 2018 Jul; 119(7):5413-5425. PubMed ID: 29363790
[TBL] [Abstract][Full Text] [Related]
6. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
[TBL] [Abstract][Full Text] [Related]
8. Linoleic acid induces secretion of extracellular vesicles from MDA-MB-231 breast cancer cells that mediate cellular processes involved with angiogenesis in HUVECs.
Garcia-Hernandez A; Leal-Orta E; Ramirez-Ricardo J; Cortes-Reynosa P; Thompson-Bonilla R; Salazar EP
Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106519. PubMed ID: 33238201
[TBL] [Abstract][Full Text] [Related]
9. Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells.
Serna-Marquez N; Villegas-Comonfort S; Galindo-Hernandez O; Navarro-Tito N; Millan A; Salazar EP
Cell Oncol (Dordr); 2013 Feb; 36(1):65-77. PubMed ID: 23179791
[TBL] [Abstract][Full Text] [Related]
10. Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).
Henkels KM; Farkaly T; Mahankali M; Segall JE; Gomez-Cambronero J
J Mol Biol; 2011 May; 408(5):850-62. PubMed ID: 21414324
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443
[TBL] [Abstract][Full Text] [Related]
12. Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.
Ye Q; Kantonen S; Gomez-Cambronero J
J Mol Biol; 2013 Feb; 425(4):755-66. PubMed ID: 23238254
[TBL] [Abstract][Full Text] [Related]
13. Role of Src/FAK in migration and invasion mediated by extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid.
Ramirez-Ricardo J; Leal-Orta E; Garcia-Hernandez A; Diaz-Aragon R; Cortes-Reynosa P; Thompson-Bonilla R; Salazar EP
Med Oncol; 2021 Mar; 38(4):40. PubMed ID: 33728516
[TBL] [Abstract][Full Text] [Related]
14. The influence of linoleic and linolenic acid on the activity and intracellular localisation of phospholipase D in COS-1 cells.
Gemeinhardt A; Alfalah M; Gück T; Naim HY; Fuhrmann H
Biol Chem; 2009 Mar; 390(3):253-8. PubMed ID: 19090716
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.
Eisen SF; Brown HA
Mol Pharmacol; 2002 Oct; 62(4):911-20. PubMed ID: 12237338
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D confers rapamycin resistance in human breast cancer cells.
Chen Y; Zheng Y; Foster DA
Oncogene; 2003 Jun; 22(25):3937-42. PubMed ID: 12813467
[TBL] [Abstract][Full Text] [Related]
17. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.
Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L
Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidic acid, phospholipase D and tumorigenesis.
Gomez-Cambronero J
Adv Biol Regul; 2014 Jan; 54():197-206. PubMed ID: 24103483
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from MDA-MB-231 breast cancer cells stimulated with linoleic acid promote an EMT-like process in MCF10A cells.
Galindo-Hernandez O; Serna-Marquez N; Castillo-Sanchez R; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):299-310. PubMed ID: 25301203
[TBL] [Abstract][Full Text] [Related]
20. Expression of phospholipase D2 in human colorectal carcinoma.
Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
